Quick Takeaways
- James E. Flynn filed SCHEDULE 13D/A for Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC).
- Disclosed ownership: 100%.
- Date of event: 21 Feb 2025.
James E. Flynn - 21 Feb 2025 SCHEDULE 13D/A Report for Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC)
- Filing Manager
- James E. Flynn
- Reporting Manager
- Deerfield Mgmt IV, L.P.
- Symbol
- OMIC
- Shares outstanding
- 1,000 shares
- Disclosed Ownership
- 1,000 shares
- Ownership
- 100%
- Form type
- SCHEDULE 13D/A
- Filing time
- 25 Feb 2025, 21:18:06 UTC
- Date of event
- 21 Feb 2025
- Previous filing
- 26 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"James E. Flynn disclosed 100% ownership in Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share (OMIC) on 21 Feb 2025."
What Changed
- Previous schedule filing date: 26 Dec 2024.
- Current filing was accepted on 25 Feb 2025, 21:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deerfield Mgmt IV, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001713467 |
| Deerfield Private Design Fund IV, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001680307 |
| Deerfield Management Company, L.P. | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001009258 |
| James E. Flynn | 100% | 1,000 | 0 | 1,000 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001352546 |